Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Chinese Academy of Medical Science, Beijing

Cancer Hospital Chinese Academy of Medical Sciences, Beijing

Peking Union Medical College Hospital, Beijing

Hunan Cancer Hospital, Changsha

Sichuan Cancer Hospital, Chendu

Sichuan Provincial People's Hospital, Chengdu

The First Affiliated Hospital of Chongqing Medical University, Chongqing

Fujian Medical University Consonancy Hospital, Fuzhou

Guangdong Provincial People's Hospital, Guangzhou

The Second Affiliated Hospital of Zhejiang University School Of Medicine, Hangzhou

The First People's Hospital of Yunnan Province, Kunming

Yunnan Cancer Hospital, Kunming

JiangXi Cancer Hospital, Nanchang

The First Affiliated Hospital of Nanchang University, Nanchang

Jiangsu Cancer Hospital, Nanjing

Jiangsu Provincial People's Hospital, Nanjing

Ningbo Medical Center Li Huili Hospital, Ningbo

Qingdao Municipal Hospital, Qingdao

Fudan University Shanghai Cancer Center, Shanghai

ShangHai Chest Hospital ShangHai JiaoTong University, Shanghai

ShangHai Pulmonary Hospital, Shanghai

Liaoning Cancer Hospital, Shenyang

Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center, Shenzhen

Hebei Cancer Hospital, Shijiazhuang

West China Hospital，Sichuan University, Sichuan

The First Affiliated Hospital of Soochow University, Suzhou

Thoracic Surgery Department Of The ShanXi Provincial Cancer Hospital, Taiyuan

Tianjin Chest Hospital, Tianjin

Affiliated Tumor Hospital of Xinjiang Medical University, Ürümqi

Weifang People's Hospital, Weifang

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

Wuhan Union Hospital Of China, Wuhan

First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

The First Affiliated Hospital of Zhengzhou University, Zhengzhou